Real-world safety and early efficacy of talquetamab in patients with heavily-pretreated relapsed/refractory multiple myeloma Meeting Abstract
| Authors: | Costa, B. A.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; Chung, D. J.; Landau, H. J.; Scordo, M.; Hassoun, H.; Maclachlan, K. H.; Shah, U. A.; Hultcrantz, M.; Hamadeh, I. S.; Giralt, S.; Mailankody, S.; Usmani, S. Z.; Hashmi, H. |
| Abstract Title: | Real-world safety and early efficacy of talquetamab in patients with heavily-pretreated relapsed/refractory multiple myeloma |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 7026 |
| End Page: | 7027 |
| Language: | English |
| ACCESSION: | WOS:001412273200006 |
| DOI: | 10.1182/blood-2024-206413 |
| PROVIDER: | wos |
| Notes: | Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
